Inovio Pharmaceuticals, Inc. INO
Set alert
As of Nov 3, 1:34 PM ET
- YTD
- -4.31%
- 1 year
- -33.40%
- Open
- 1.87
- Prev close
- 1.89
- Mkt cap
- 172.16M
- Vol
- 34.88M
- Avg vol
- 8.60M
- EPS
- -0.90
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.60
- High
- 2.04
- Forward P/E
- -0.48
- Beta
- 0.83
- Short ratio
- 11.22
- Inst. own
- 33.51%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 6, 2024
- 50-d avg
- 4.56
- 200-d avg
- 8.18
- 1y target
- 10.67
5D chart
Signals (108)
| Name | Time | Ago |
|---|---|---|
| RSI: Oversold | Nov 3, 1:10 PM | 24 minutes ago |
| SMA: Bearish | Nov 3, 11:55 AM | 1 hour ago |
| MACD: Sell Signal | Nov 3, 11:45 AM | 1 hour ago |
| SMA: Bullish | Nov 3, 10:55 AM | 2 hours ago |
| SMA: Bearish | Nov 3, 10:40 AM | 2 hours ago |
| SMA: Bearish | Nov 3, 10:40 AM | 2 hours ago |
| SMA: Bullish | Nov 3, 10:15 AM | 3 hours ago |
| MACD: Buy Signal | Nov 3, 10:10 AM | 3 hours ago |
| SMA: Bullish | Nov 3, 10:00 AM | 3 hours ago |
| RSI: Oversold | Nov 3, 9:30 AM | 4 hours ago |
| SMA: Bearish | Nov 2, 3:05 PM | 22 hours ago |
| SMA: Bearish | Nov 2, 3:05 PM | 22 hours ago |
| SMA: Bullish | Nov 2, 2:50 PM | 22 hours ago |
| SMA: Bearish | Nov 2, 2:45 PM | 22 hours ago |
| SMA: Bullish | Nov 2, 2:35 PM | 22 hours ago |
| SMA: Bearish | Nov 2, 2:20 PM | 23 hours ago |
| SMA: Bullish | Nov 2, 2:00 PM | 23 hours ago |
| SMA: Bearish | Nov 2, 1:55 PM | 23 hours ago |
| SMA: Bearish | Nov 2, 1:55 PM | 23 hours ago |
| SMA: Bullish | Nov 2, 1:25 PM | 1 day ago |
Newest 20 of 108.
News
1 hour ago schaeffersresearch.com
4 Biotech Stocks Seeing Unusual Options Volume Today
Four pharmaceutical and biotech stocks are seeing unusual options activity today, with Inovio Pharmaceuticals Inc (NASDAQ:INO), Aquestive Therapeutics Inc (NASDAQ:AQST), X4 Pharmaceuticals Inc…
21 hours ago prnewswire.com
INOVIO to Report Third Quarter 2026 Financial Results on November 10, 2026
PLYMOUTH MEETING, Pa., Nov. 2, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from…
21 hours ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) stock moved upwards by 16.2% to $4.67 during Monday's after-market session. The market value of their outstanding shares is at $9.1 million. Cerus…
21 hours ago prnewswire.com
INOVIO to Participate in Upcoming Scientific Conferences
PLYMOUTH MEETING, Pa., Nov. 2, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from…
23 hours ago seekingalpha.com
Inovio Pharmaceuticals, Inc. (INO) Discusses FDA Accelerated Approval and Commercial Launch of VOCERYQ for RRP Transcript
Inovio Pharmaceuticals, Inc. (INO) Discusses FDA Accelerated Approval and Commercial Launch of VOCERYQ for RRP Transcript
1 day ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Inovio Pharmaceuticals (NASDAQ:INO) shares rose 211.2% to $1.88 during Monday's regular session. The company's market cap stands at $62.2 million. BeyondSpring (NASDAQ:BYSI) stock moved…
1 day ago benzinga.com
Crude Oil Tumbles 7%; ISM Manufacturing PMI Rises In October
U.S. stocks climbed as manufacturing data beat estimates; consumer shares surged, oil fell 7%, and Inovio, Perion and Evgo rallied.
1 day ago benzinga.com
Inovio Stock Soars Following FDA Approval for Rare Respiratory Disease Immunotherapy
Inovio stock surges after FDA accelerated approval of Voceryq, an immunotherapy reducing surgeries for adults with recurrent respiratory papillomatosis.
1 day ago marketbeat.com
Inovio Wins FDA Approval for VOCERYQ, Its First Commercial Product
Inovio Pharmaceuticals NASDAQ: INO said the U.S. Food and Drug Administration granted accelerated approval to VOCERYQ, formerly known as INO-3107, as a nonsurgical treatment intended to reduce the…
1 day ago benzinga.com
Dow Jumps Over 400 Points; Marriott Posts Upbeat Q3 Earnings
U.S. stocks rose Monday, led by a 400-point Dow gain. Marriott beat estimates; Inovio surged 195%, while oil fell 6% and Karyopharm sank 79%.
1 day ago benzinga.com
Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Rise Ahead of Apple, Palantir Earnings; RYAAY, USLM, INO in Focus (UPDATED)
U.S. stocks rose on Monday, as the Dow Jones, S&P 500, and Nasdaq 100 index futures advanced, following Friday's lower close.
1 day ago benzinga.com
This CrowdStrike Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Analysts upgraded PMT, MHK, CRWD, INO and AON; targets rose for MHK, CRWD and INO, while PMT’s target fell.
-
1 day ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Inovio Pharmaceuticals (NASDAQ:INO) shares increased by 232.0% to $2.0 during Monday's pre-market session. The company's market cap stands at $62.2 million. AngioDynamics (NASDAQ:ANGO) shares…
-
1 day ago benzinga.com
HC Wainwright & Co. Upgrades Inovio Pharmaceuticals to Buy, Announces $5 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju upgrades Inovio Pharmaceuticals (NASDAQ:INO) from Neutral to Buy and announces $5 price target.
1 day ago benzinga.com
Why Inovio Pharmaceuticals Shares Are Trading Higher By Over 230%; Here Are 20 Stocks Moving Premarket
Shares of Inovio Pharmaceuticals Inc (NASDAQ:INO) rose sharply in pre-market trading after the company disclosed that the FDA has granted accelerated approval for Voceryq for the treatment of adults…
1 day ago benzinga.com
Why Inovio Pharmaceuticals Shares Are Trading Higher By Over 230%; Here Are 20 Stocks Moving Premarket
Inovio shares surged 230% premarket after FDA accelerated Voceryq approval; ClearOne and 22nd Century gained, while RedCloud fell 33.5%.
1 day ago benzinga.com
Apple, Marriott International and 3 Stocks to Watch Heading Into Monday
Stocks in focus: Apple, Marriott and Estée Lauder report earnings; Inovio wins FDA approval, while U.S. Lime posts disappointing results.
3 days ago prnewswire.com
INOVIO Announces FDA Accelerated Approval of VOCERYQ™, an Immunotherapy to Reduce the Frequency of Surgery in Adults with Recurrent Respiratory Papillomatosis (RRP)
INOVIO delivers a new nonsurgical treatment option with a broad indication for adults living with RRP, a rare and debilitating disease that often requires surgery VOCERYQ™ is a plasmid DNA-based…
3 days ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Inovio Pharmaceuticals (NASDAQ:INO) stock moved upwards by 292.6% to $2.37 during Friday's after-market session. The market value of their outstanding shares is at $79.8 million. Capricor…
-
1 week ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers XORTX Therapeutics (NASDAQ:XRTX) shares moved upwards by 19.3% to $1.14 during Tuesday's after-market session. The company's market cap stands at $1.8 million. Edesa Biotech (NASDAQ:EDSA)…
1 week ago prnewswire.com
INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science
PLYMOUTH MEETING, Pa., Oct. 20, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and…
1 month ago defenseworld.net
Critical Survey: Pyxis Oncology (NASDAQ:PYXS) versus Inovio Pharmaceuticals (NASDAQ:INO)
Pyxis Oncology (NASDAQ: PYXS - Get Free Report) and Inovio Pharmaceuticals (NASDAQ: INO - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the…
1 month ago zacks.com
Bet on 4 Top-Ranked Stocks With Rising P/E
Tap four stocks with increasing P/E ratios to try out an out-of-the-box investment approach.
1 month ago seekingalpha.com
Inovio Pharmaceuticals, Inc. (INO) Presents at H.C. Wainwright 28th Annual Global Investment Conference Prepared Remarks Transcript
Inovio Pharmaceuticals, Inc. (INO) Presents at H.C. Wainwright 28th Annual Global Investment Conference Prepared Remarks Transcript
1 month ago marketbeat.com
Inovio Nears FDA Decision on INO-3107 as Oct. 30 PDUFA Date Looms
Inovio Pharmaceuticals NASDAQ: INO said its biologics license application for INO-3107, an investigational DNA medicine for recurrent respiratory papillomatosis, or RRP, remains under U.S. Food and…
1 month ago marketbeat.com
Inovio Pharmaceuticals Nears Oct. 30 FDA Decision for INO-3107 in RRP
Inovio Pharmaceuticals NASDAQ: INO is approaching an October 30 PDUFA date for INO-3107, its lead DNA medicine candidate for recurrent respiratory papillomatosis, or RRP, President and CEO Jacky Shea…
1 month ago seekingalpha.com
Inovio Pharmaceuticals, Inc. (INO) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript
Inovio Pharmaceuticals, Inc. (INO) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript
2 months ago zacks.com
Bet on 5 Top-Ranked Stocks With Rising P/E
Tap these five stocks - CURI, INO, GDS, NMG and CCOI - with increasing P/E ratios to try out an out-of-the-box approach.
2 months ago prnewswire.com
INOVIO to Participate in Upcoming Investor Conferences
PLYMOUTH MEETING, Pa., Sept. 1, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from…
-
2 months ago benzinga.com
World Health Organization Director General Determined That The Ebola Epidemic In DRC Still Meets Criteria Of Public Health Emergency Of International Concern, But Not Those Of A Pandemic Emergency
https://www.who.int/news/item/28-08-2026-second-meeting-of-the-ihr-emergency-committee-on-the-epidemic-of-ebola-bundibugyo-virus-disease-in-the-democratic-republic-of-the-congo---meeting-report
-
2 months ago benzinga.com
Jefferies Upgrades Inovio Pharmaceuticals to Buy, Raises Price Target to $3
Jefferies analyst Roger Song upgrades Inovio Pharmaceuticals (NASDAQ:INO) from Hold to Buy and raises the price target from $1.8 to $3.
2 months ago marketbeat.com
Inovio Pharmaceuticals Q2 Earnings Call Highlights
Inovio Pharmaceuticals NASDAQ: INO said the U.S. Food and Drug Administration has completed several key steps in its review of the company's biologics license application for INO-3107, an…
2 months ago seekingalpha.com
Inovio Pharmaceuticals, Inc. (INO) Q2 2026 Earnings Call Transcript
Inovio Pharmaceuticals, Inc. (INO) Q2 2026 Earnings Call Transcript
2 months ago prnewswire.com
INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights
U.S. Food and Drug Administration (FDA) review of Biologics License Application (BLA) for INO-3107 as a treatment for Recurrent Respiratory Papillomatosis (RRP) advancing with a target Prescription…
-
2 months ago benzinga.com
Inovio Pharmaceuticals Q2 EPS $(0.07) Beats $(0.22) Estimate
Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.22) by 68.18 percent. This is a 88.52 percent increase over losses…
3 months ago zacks.com
Bet on 5 Top-Ranked Stocks With Rising P/E
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.
3 months ago prnewswire.com
INOVIO to Report Second Quarter Financial Results on August 12, 2026
PLYMOUTH MEETING, Pa., Aug. 4, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from…
-
3 months ago benzinga.com
Piper Sandler Reiterates Overweight on Inovio Pharmaceuticals, Lowers Price Target to $4
Piper Sandler analyst Edward Tenthoff reiterates Inovio Pharmaceuticals (NASDAQ:INO) with a Overweight and lowers the price target from $6 to $4.
3 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular session. GlucoTrack (NASDAQ:GCTK) shares moved upwards by 79.85% to $0.51. The company's market cap…
3 months ago benzinga.com
Nasdaq Surges Over 600 Points; Microsoft Shares Jump After Upbeat Q4 Results
US stocks rise with Nasdaq up 600 points, Dow up 0.69% and S&P 500 up 1.29%. Tech shares up 5%, communication services down 3.3%. Microsoft jumps 15% after strong earnings.
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Nuwellis (NASDAQ:NUWE) stock rose 119.0% to $4.14 during Thursday's pre-market session. GlucoTrack (NASDAQ:GCTK) stock increased by 47.36% to $0.42. The market value of their outstanding…
3 months ago benzinga.com
Why Microsoft Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket
Microsoft (NASDAQ: MSFT) reported strong Q4 results, beating revenue and earnings estimates. Shares jumped 7.8% in pre-market trading.
3 months ago benzinga.com
Inovio Stock Falls 21% After Hours: Here's What's Going On
Inovio stock fell after hours after pricing a $20 million public offering of common stock and warrants.
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Nuwellis (NASDAQ:NUWE) stock rose 40.2% to $2.65 during Wednesday's after-market session. Onconetix (NASDAQ:ONCO) shares moved upwards by 27.46% to $0.96. The company's market cap stands at…
-
3 months ago benzinga.com
INOVIO Pharmaceuticals Announces Proposed Public Offering Of Shares And Warrants
INOVIO Pharmaceuticals, Inc. (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and…
-
5 months ago benzinga.com
HC Wainwright & Co. Maintains Neutral on Inovio Pharmaceuticals, Lowers Price Target to $2.5
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Inovio Pharmaceuticals (NASDAQ:INO) with a Neutral and lowers the price target from $3 to $2.5.
-
5 months ago benzinga.com
Inovio Pharmaceuticals' Partner For VGX-3100 In China, ApolloBio, Announces Topline Results From Its Pivotal Phase 3 Trial Of VGX-3100; Trial Met Its Predefined Primary Efficacy Endpoint And Demonstrated An Overall Favorable Safety And Tolerability Profile
INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today…
-
5 months ago benzinga.com
U.S. CDC Says Will Enhance Screening And Monitoring Of Travelers Arriving From Areas Affected By Ebola Outbreaks; Will Coordinate With Airlines, Others To Manage Travelers Who May Have Already Been Exposed To Ebola; Will Enhance Contract Tracing, Hospital Readiness Nationwide
https://www.cdc.gov/ebola/situation-summary/index.html
-
5 months ago benzinga.com
Full Transcript: Inovio Pharmaceuticals Q1 2026 Earnings Call
Full Transcript: Inovio Pharmaceuticals Q1 2026 Earnings Call
